This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its chiral structure makes it particularly valuable in the development of enantiomerically pure drugs, which often exhibit improved efficacy and reduced side effects. Specifically, it is employed in the production of certain antiviral and central nervous system (CNS) targeting medications. Additionally, its morpholine ring contributes to enhanced bioavailability and metabolic stability in drug formulations. The compound is also explored in research settings for the development of novel therapeutic agents, particularly in areas requiring selective receptor modulation.